Modelling and finite-time stability analysis of psoriasis pathogenesis

References

• Amodio, G., & Gregori, S. (2012). Dendritic cells a double-edge sword in autoimmune responses. Frontiers in Immunology, 3, 1–9, Article 233.
   PubMed Web of Science ®Google Scholar
• Bettelli, E., Korn, T., & Kuchroo, V.K. (2007). Th17: The third member of the effector T cell trilogy. Current Opinion in Immunology, 19, 652–657.
   PubMed Web of Science ®Google Scholar
• Bhat, S., & Bernstein, D. (2000). Finite-time stability of continuous autonomous systems. SIAM Journal of Control and Optimization, 38, 751–766.
   Web of Science ®Google Scholar
• Blauvelt, A. (2007). New concepts in the pathogenesis and treatment of psoriasis: Key roles for IL-23, IL-17A and TGF-β1. Expert Review of Dermatology, 2, 69–78.
   Google Scholar
• Blauvelt, A., Asada, H., Klaus-Kovtun, V., Altman, D.J., Lucey, D.R., & Katz, S.I. (1996). Interleukin-15 mRNA is expressed by human keratinocytes Langerhans cells, and blood-derived dendritic cells and is downregulated by ultraviolet B radiation. Journal of Investigative Dermatology, 106, 1047–1052.
   PubMed Web of Science ®Google Scholar
• Bonish, B., Jullien, D., Dutronc, Y., Huang, B.B., Modlin, R., Spada, F.M., ...Nickoloff, B.J. (2000). Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-production by NK-T Cells. The Journal of Immunology, 165, 4076–4085.
   PubMed Web of Science ®Google Scholar
• Brito-Luna, M., Villanueva-Quintero, D., Sandoval-Talamantes, A., Fafutis-Morris, M., Graciano-Machuca, O., Sanchez-Hernandez, P., & Alvarado-Navarro, A. (2016). Correlation of IL-12, IL-22, and IL-23 in patients with psoriasis and metabolic syndrome. Preliminary report. Cytokine, 85, 130–136.
   PubMed Web of Science ®Google Scholar
• Bulfone-Paus, S., Ungureanu, D., Pohl, T., Lindner, G., Paus, R., Ruckert, R., ...Kunzendorf, U. (1997). Interleukin-15 protects from lethal apoptosis in vivo. Nature Medicine, 3, 1124–1128.
   PubMed Web of Science ®Google Scholar
• Cabrijan, L., Lipozencić, J., Batinac, T., Peternel, S., & Pastar, Z. (2009). The role of CD4 and CD8 lymphocytes and macrophages in psoriasis vulgaris. Acta Dermatovenerologica Croatica, 17, 162–165.
   PubMed Web of Science ®Google Scholar
• Chan, J.R., Blumenschein, W., Murphy, E., Diveu, C., Wiekowski, M., Abbondanzo, S., ...Bowman, E.P. (2006). IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. The Journal of Experimental Medicine, 203, 2577–2587.
   PubMed Web of Science ®Google Scholar
• Chaudhari, U., Romano, P., Mulcahy, L., Dooley, L., Baker, D., & Gottlieb, A. (2001). Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: A randomised trial. The Lancet, 357, 1842–1847.
   PubMed Web of Science ®Google Scholar
• Clark, A., & Kupper, T.S. (2006). Misbehaving macrophages in the pathogenesis of psoriasis. The Journal of Clinical Investigation, 116, 2084–2087.
   PubMed Web of Science ®Google Scholar
• Couper, K.N., Blount, D.G., & Riley, E.M. (2008). IL-10: The master regulator of immunity to infection. The Journal of Immunology, 180, 5771–5777.
   PubMed Web of Science ®Google Scholar
• Danilenko, D.M. (2008). Review paper: Preclinical models of psoriasis. Veterinary Pathology Online, 45, 563–575.
   PubMed Web of Science ®Google Scholar
• Dunphy, S., & Gardiner, C.M. (2011). NK cells and psoriasis. Journal of Biomedicine and Biotechnology, Article ID 248317, 10 p.
   PubMedGoogle Scholar
• Elder, J.T. (2007). IL-15 and psoriasis: Another genetic link to Th17 ? Journal of Investigative Dermatology, 127, 2495–2497.
   PubMed Web of Science ®Google Scholar
• Fierlbeck, G., & Rassner, G. (1990). Treatment of psoriasis and psoriatic arthritis with interferon gamma. Journal of Investigative Dermatology, 95, 138S–141S.
   PubMed Web of Science ®Google Scholar
• Filippov, A.F. (1988). Differential equations with discontinuous right hand sides. Dordrecht: Kluwer Academic.
   Google Scholar
• Fujita, H. (2013). The role of IL-22 and Th22 cells in human skin diseases. Journal of Dermatological Science, 72, 3–8.
   PubMed Web of Science ®Google Scholar
• Fujita, H., Nograles, K.E., Kikuchi, T., Gonzalez, J., Carucci, J.A., & Krueger, J.G. (2009). Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proceedings of the National Academy of Sciences, 106, 21795–21800.
   PubMed Web of Science ®Google Scholar
• Gandolfi, A., Iannelli, M., & Marinoschi, G. (2011). An age-structured model of epidermis growth. Journal of Mathematical Biology, 62, 111–141.
   PubMed Web of Science ®Google Scholar
• Goodfellow, M., Phillips, N.E., Manning, C., Galla, T., & Papalopulu, N. (2014). microRNA input into a neural ultradian oscillator controls emergence and timing of alternative cell states. Nature Communications, 5, 3399.
   PubMed Web of Science ®Google Scholar
• Grabe, N., & Neuber, K. (2005). A multicellular systems biology model predicts epidermal morphology, kinetics and Ca2 + flow. Bioinformatics, 21, 3541–3547.
   PubMed Web of Science ®Google Scholar
• Grabe, N., & Neuber, K. (2007). Simulating psoriasis by altering transit amplifying cells. Bioinformatics, 23, 1309–1312.
   PubMed Web of Science ®Google Scholar
• Haimo, V.T. (1986). Finite time controllers. SIAM Journal on Control and Optimization, 24, 760–770.
   Web of Science ®Google Scholar
• Hofmann, S.R., Rösen-Wolff, A., Tsokos, G.C., & Hedrich, C.M. (2012). Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury. Clinical Immunology, 143, 116–127.
   PubMed Web of Science ®Google Scholar
• Johnson-Huang, L.M., Lowes, M.A., & Krueger, J.G. (2012). Putting together the psoriasis puzzle: an update on developing targeted therapies. Disease Models & Mechanisms, 5, 423–433.
   PubMed Web of Science ®Google Scholar
• Khalil, H.K. (1996). Nonlinear systems (2nd ed. ). Uppere Saddle River, NJ: Prentice Hall.
   Google Scholar
• Leonardi, C.L., Powers, J.L., Matheson, R.T., Goffe, B.S., Zitnik, R., Wang, A., & Gottlieb, A.B. (2003). Etanercept as monotherapy in patients with psoriasis. New England Journal of Medicine, 349, 2014–2022.
   PubMed Web of Science ®Google Scholar
• Lew, W., Bowcock, A.M., & Krueger, J.G. (2004). Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and ‘Type 1’ inflammatory gene expression. Trends in Immunology, 25, 295–305.
   PubMed Web of Science ®Google Scholar
• Lowes, M.A., Bowcock, A.M., & Krueger, J.G. (2007). Pathogenesis and therapy of psoriasis. Nature, 445, 866–873.
   PubMed Web of Science ®Google Scholar
• Lowes, M.A., Surez-Farias, M., & Krueger, J.G. (2014). Immunology of psoriasis. Annual Review of Immunology, 32, 227–255, PMID: 24655295.
   PubMed Web of Science ®Google Scholar
• Ma, C.S., Suryani, S., Avery, D.T., Chan, A., Nanan, R., Santner-Nanan, B., ...Tangye, S.G. (2009). Early commitment of naïve human CD4(+) T cells to the T follicular helper (T(FH)) cell lineage is induced by IL-12. Immunology & Cell Biology, 87, 590–600.
   PubMed Web of Science ®Google Scholar
• Monk, N. (2003). Oscillatory expression of Hes1, p53, and NF-kappa B driven by transcriptional time delays. Current Biology, 13, 1409–1413.
   PubMed Web of Science ®Google Scholar
• Nestle, F.O., Di Meglio, P., Qin, J.Z., & Nickoloff, B.J. (2009). Skin immune sentinels in health and disease. Nature Reviews Immunology, 9, 679–691.
   PubMed Web of Science ®Google Scholar
• Nograles, K.E., Davidovici, B., & Krueger, J.G. (2010). New insights in the immunologic basis of psoriasis. Seminars in Cutaneous Medicine and Surgery, 29, 3–9.
   PubMed Web of Science ®Google Scholar
• Orlov, Y. (2005). Finite time stability and robust control synthesis of uncertain switched systems. SIAM Journal on Control and Optimization, 43, 1253–1271.
   Web of Science ®Google Scholar
• Oza, H.B., Spurgeon, S.K., & Valeyev, N.V. (2014). Non-Lipschitz growth functions as a natural way of modelling finite time behaviour in auto-immune dynamics. In Proceedings of the IFAC World Congress (Vol. 19, pp. 11611–11616). Amsterdam: Elsevier.
   Google Scholar
• Piskin, G., Sylva-Steenland, R.M.R., Bos, J.D., & Teunissen, M.B.M. (2006). In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: Enhanced expression in psoriatic skin. The Journal of Immunology, 176, 1908–1915.
   PubMed Web of Science ®Google Scholar
• Raphael, I., Nalawade, S., Eagar, T.N., & Forsthuber, T.G. (2015). T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine, 74, 5–17.
   PubMed Web of Science ®Google Scholar
• Rapin, N., Mosekilde, E., & Lund, O. (2011). Bistability in autoimmune diseases. Autoimmunity, 44, 256–260.
   PubMed Web of Science ®Google Scholar
• Reich, K., Nestle, F.O., Papp, K., Ortonne, J.P., Evans, R., Guzzo, C., ...Griffiths, C.E.M. (2005). Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: A phase III, multicentre, double-blind trial. The Lancet, 366, 1367–1374.
   PubMed Web of Science ®Google Scholar
• Roy, P.K., Bhadra, J., & Chattopadhyay, B. (2010). Mathematical modeling on immunopathogenesis in chronic plaque of psoriasis: A theoretical study. In Proceedings of the World Congress on Engineering (Vol. 1, pp. 550–555). IAENG: Hong Kong.
   Google Scholar
• Roy, P.K., & Datta, A. (2012). Negative feedback control may regulate cytokines effect during growth of keratinocytes in the chronic plaque of psoriasis: A mathematical study. International Journal of Applied Mathematics, 25, 233–254.
   Google Scholar
• Rückert, R., Asadullah, K., Seifert, M., Budagian, V.M., Arnold, R., Trombotto, C., … Bulfone-Paus, S. (2000). Inhibition of keratinocyte apoptosis by IL-15: A new parameter in the pathogenesis of psoriasis ? Journal of immunology, 165, 2240–2250.
   PubMed Web of Science ®Google Scholar
• Sabat, R. (2010). IL-10 family of cytokines. Cytokine & Growth Factor Reviews, 21, 315–324.
   PubMed Web of Science ®Google Scholar
• Savill, N.J. (2003). Mathematical models of hierarchically structured cell populations under equilibrium with application to the epidermis. Cell Proliferation, 36, 1–26.
   PubMed Web of Science ®Google Scholar
• Schaller, G., & Meyer-Hermann, M. (2007). A modelling approach towards epidermal homoeostasis control. Journal of Theoretical Biology, 247, 554–573.
   PubMed Web of Science ®Google Scholar
• Schroder, K., Hertzog, P.J., Ravasi, T., & Hume, D.A. (2004). Interferon-γ: An overview of signals, mechanisms and functions. Journal of Leukocyte Biology, 75, 163–189.
   PubMed Web of Science ®Google Scholar
• Shirakata, Y. (2010). Regulation of epidermal keratinocytes by growth factors. Journal of Dermatological Science, 59, 73–80.
   PubMed Web of Science ®Google Scholar
• Sun, T., McMinn, P., Coakley, S., Holcombe, M., Smallwood, R., & MacNeil, S. (2007). An integrated systems biology approach to understanding the rules of keratinocyte colony formation. Journal of The Royal Society Interface, 4, 1077–1092.
   PubMed Web of Science ®Google Scholar
• Suzuki, E., Mellins, E.D., Gershwin, M.E., Nestle, F.O., & Adamopoulos, I.E. (2014). The IL-23/IL-17 axis in psoriatic arthritis. Autoimmunity Reviews, 13, 496–502.
   PubMed Web of Science ®Google Scholar
• Valeyev, N., Hundhausen, C., Umezawa, Y., Kotov, N., Williams, G., Clop, A., ...Nestle, F. (2010). A systems model for immune cell interactions unravels the mechanism of inflammation in human skin. PLoS Computational Biology, 6, e1001024.
   PubMed Web of Science ®Google Scholar
• Weatherhead, S.C., Farr, P.M., Jamieson, D., Hallinan, J.S., Lloyd, J.J., Wipat, A., & Reynolds, N.J. (2011). Keratinocyte apoptosis in epidermal remodeling and clearance of psoriasis induced by UV radiation. Journal of Investigative Dermatology, 131. 1916–1926.
   PubMed Web of Science ®Google Scholar
• Wolk, K., Haugen, H., Xu, W., Witte, E., Waggie, K., Anderson, M., ...Sabat, R. (2009). IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not. Journal of Molecular Medicine, 87, 523–536.
   PubMed Web of Science ®Google Scholar
• Yim, K.M., & Armstrong, A.W. (2016). Updates on cardiovascular comorbidities associated with psoriatic diseases: Epidemiology and mechanisms. Rheumatology International, 1–9. doi: 10.1007/s00296-016-3487-2
   PubMed Web of Science ®Google Scholar
• Young, K., Utkin, V., & Ozguner, U. (1999). A control engineer's guide to sliding mode control. IEEE Transactions on Control Systems Technology, 7, 328–342.
   Web of Science ®Google Scholar
• Zaba, L.C., Fuentes-Duculan, J., Eungdamrong, N.J., Abello, M.V., Novitskaya, I., Pierson, K.C., ...Lowes, M.A. (2009). Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. The Journal of Investigative Dermatology, 129, 79–88.
   PubMed Web of Science ®Google Scholar
• Zhang, H., Hou, W., Henrot, L., Schnebert, S., Dumas, M., Heusèle, C., & Yang, J. (2015). Modelling epidermis homoeostasis and psoriasis pathogenesis. Journal of The Royal Society Interface, 12. doi: 10.1098/rsif.2014.1071
   Web of Science ®Google Scholar
• Zimmermann, M., Koreck, A., Meyer, N., Basinski, T., Meiler, F., Simone, B., ...Akdis, C.A. (2011). TNF-like weak inducer of apoptosis (TWEAK) and TNF-α cooperate in the induction of keratinocyte apoptosis. Journal of Allergy and Clinical Immunology, 127, 200–207.
   PubMed Web of Science ®Google Scholar